Signaling of MK2 sustains robust AP1 activity for triple negative breast cancer tumorigenesis through direct phosphorylation of JAB1

Abstract Triple negative breast cancer (TNBC) cells are generally more invasive than estrogen receptor-positive (ER + ) breast cancer cells. Consistent with the importance of activator protein 1 (AP1) transcription factors in invasion, AP1 activity is much higher in TNBC lines than ER + lines. In TN...

Full description

Bibliographic Details
Main Authors: Haoming Chen, Ravi Padia, Tao Li, Yue Li, Bin Li, Lingtao Jin, Shuang Huang
Format: Article
Language:English
Published: Nature Portfolio 2021-07-01
Series:npj Breast Cancer
Online Access:https://doi.org/10.1038/s41523-021-00300-1
_version_ 1797428236704022528
author Haoming Chen
Ravi Padia
Tao Li
Yue Li
Bin Li
Lingtao Jin
Shuang Huang
author_facet Haoming Chen
Ravi Padia
Tao Li
Yue Li
Bin Li
Lingtao Jin
Shuang Huang
author_sort Haoming Chen
collection DOAJ
description Abstract Triple negative breast cancer (TNBC) cells are generally more invasive than estrogen receptor-positive (ER + ) breast cancer cells. Consistent with the importance of activator protein 1 (AP1) transcription factors in invasion, AP1 activity is much higher in TNBC lines than ER + lines. In TNBC cells, robust AP1 activity is facilitated by both ERK and p38MAPK signaling pathways. While ERK signaling pathway regulates AP1 activity by controlling the abundance of AP1 transcription factors, p38MAPK signaling pathway does it by enhancing AP1 binding to AP1 sites without altering their abundance. Here, we show that p38MAPK regulation of AP1 activity involves both MAPKAPK2 (MK2) and JAB1, a known JUN-binding protein. MK2 not only interacts with JAB1 but also directly phosphorylates JAB1 at Ser177 in TNBC cells. Interestingly, Ser177 phosphorylation does not affect JAB1 and JUN interaction. Instead, interfering with p38MAPK signaling pathway or introducing an S to A point mutation at Ser177 of JAB1 reduces JUN recruitment to the AP1 sites in cyclin D1, urokinase plasminogen activator (uPA) and uPA receptor promoters. Moreover, knockdown of JAB1 diminishes >60% of AP1 transcriptional activity in TNBC cells. Taken together, these results indicate that MK2-mediated phosphorylation of JAB1 facilitates JUN recruitment to AP1 sites, thus augmenting AP1 activity. In line with the role of JAB1 in AP1 activity, silencing JAB1 leads to dramatic reduction in TNBC cell growth, in vitro invasion and in vivo tumor outgrowth. This study suggests that the p38MAPK-MK2 signaling pathway promotes TNBC tumorigenesis by sustaining robust AP1 activity.
first_indexed 2024-03-09T08:56:11Z
format Article
id doaj.art-6809040fae854e9e929618df09a0fab9
institution Directory Open Access Journal
issn 2374-4677
language English
last_indexed 2024-03-09T08:56:11Z
publishDate 2021-07-01
publisher Nature Portfolio
record_format Article
series npj Breast Cancer
spelling doaj.art-6809040fae854e9e929618df09a0fab92023-12-02T13:07:59ZengNature Portfolionpj Breast Cancer2374-46772021-07-017111310.1038/s41523-021-00300-1Signaling of MK2 sustains robust AP1 activity for triple negative breast cancer tumorigenesis through direct phosphorylation of JAB1Haoming Chen0Ravi Padia1Tao Li2Yue Li3Bin Li4Lingtao Jin5Shuang Huang6The Ministry of Education Key Laboratory of Contemporary Anthropology, College of Life Science, Fudan UniversityDepartment of Anatomy and Cell Biology, University of Florida College of MedicineDepartment of Anatomy and Cell Biology, University of Florida College of MedicineDepartment of Anatomy and Cell Biology, University of Florida College of MedicineDepartment of Anatomy and Cell Biology, University of Florida College of MedicineDepartment of Anatomy and Cell Biology, University of Florida College of MedicineDepartment of Anatomy and Cell Biology, University of Florida College of MedicineAbstract Triple negative breast cancer (TNBC) cells are generally more invasive than estrogen receptor-positive (ER + ) breast cancer cells. Consistent with the importance of activator protein 1 (AP1) transcription factors in invasion, AP1 activity is much higher in TNBC lines than ER + lines. In TNBC cells, robust AP1 activity is facilitated by both ERK and p38MAPK signaling pathways. While ERK signaling pathway regulates AP1 activity by controlling the abundance of AP1 transcription factors, p38MAPK signaling pathway does it by enhancing AP1 binding to AP1 sites without altering their abundance. Here, we show that p38MAPK regulation of AP1 activity involves both MAPKAPK2 (MK2) and JAB1, a known JUN-binding protein. MK2 not only interacts with JAB1 but also directly phosphorylates JAB1 at Ser177 in TNBC cells. Interestingly, Ser177 phosphorylation does not affect JAB1 and JUN interaction. Instead, interfering with p38MAPK signaling pathway or introducing an S to A point mutation at Ser177 of JAB1 reduces JUN recruitment to the AP1 sites in cyclin D1, urokinase plasminogen activator (uPA) and uPA receptor promoters. Moreover, knockdown of JAB1 diminishes >60% of AP1 transcriptional activity in TNBC cells. Taken together, these results indicate that MK2-mediated phosphorylation of JAB1 facilitates JUN recruitment to AP1 sites, thus augmenting AP1 activity. In line with the role of JAB1 in AP1 activity, silencing JAB1 leads to dramatic reduction in TNBC cell growth, in vitro invasion and in vivo tumor outgrowth. This study suggests that the p38MAPK-MK2 signaling pathway promotes TNBC tumorigenesis by sustaining robust AP1 activity.https://doi.org/10.1038/s41523-021-00300-1
spellingShingle Haoming Chen
Ravi Padia
Tao Li
Yue Li
Bin Li
Lingtao Jin
Shuang Huang
Signaling of MK2 sustains robust AP1 activity for triple negative breast cancer tumorigenesis through direct phosphorylation of JAB1
npj Breast Cancer
title Signaling of MK2 sustains robust AP1 activity for triple negative breast cancer tumorigenesis through direct phosphorylation of JAB1
title_full Signaling of MK2 sustains robust AP1 activity for triple negative breast cancer tumorigenesis through direct phosphorylation of JAB1
title_fullStr Signaling of MK2 sustains robust AP1 activity for triple negative breast cancer tumorigenesis through direct phosphorylation of JAB1
title_full_unstemmed Signaling of MK2 sustains robust AP1 activity for triple negative breast cancer tumorigenesis through direct phosphorylation of JAB1
title_short Signaling of MK2 sustains robust AP1 activity for triple negative breast cancer tumorigenesis through direct phosphorylation of JAB1
title_sort signaling of mk2 sustains robust ap1 activity for triple negative breast cancer tumorigenesis through direct phosphorylation of jab1
url https://doi.org/10.1038/s41523-021-00300-1
work_keys_str_mv AT haomingchen signalingofmk2sustainsrobustap1activityfortriplenegativebreastcancertumorigenesisthroughdirectphosphorylationofjab1
AT ravipadia signalingofmk2sustainsrobustap1activityfortriplenegativebreastcancertumorigenesisthroughdirectphosphorylationofjab1
AT taoli signalingofmk2sustainsrobustap1activityfortriplenegativebreastcancertumorigenesisthroughdirectphosphorylationofjab1
AT yueli signalingofmk2sustainsrobustap1activityfortriplenegativebreastcancertumorigenesisthroughdirectphosphorylationofjab1
AT binli signalingofmk2sustainsrobustap1activityfortriplenegativebreastcancertumorigenesisthroughdirectphosphorylationofjab1
AT lingtaojin signalingofmk2sustainsrobustap1activityfortriplenegativebreastcancertumorigenesisthroughdirectphosphorylationofjab1
AT shuanghuang signalingofmk2sustainsrobustap1activityfortriplenegativebreastcancertumorigenesisthroughdirectphosphorylationofjab1